View in EDS HTML Full Text PDF Full Text

Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients.

Saved in:
Bibliographic Details
Title: Immunogenicity and safety of a third dose of anti‐SARS‐CoV‐2 BNT16b2 vaccine in liver transplant recipients.
Authors: Toniutto, Pierluigi1 (AUTHOR) pierluigi.toniutto@uniud.it, Cussigh, Annarosa2 (AUTHOR), Cmet, Sara2 (AUTHOR), Bitetto, Davide1 (AUTHOR), Fornasiere, Ezio1 (AUTHOR), Fumolo, Elisa1 (AUTHOR), Fabris, Martina2 (AUTHOR), D'Aurizio, Federica2 (AUTHOR), Fabris, Carlo1 (AUTHOR), Grillone, Lucrezia3 (AUTHOR), Sartor, Assunta4 (AUTHOR), Curcio, Francesco2 (AUTHOR), Falleti, Edmondo1 (AUTHOR)
Source: Liver International. Feb2023, Vol. 43 Issue 2, p452-461. 10p. 4 Charts, 4 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14783223
DOI:10.1111/liv.15331